Bansisons Tea Industries Ltd — Board Meeting, 14-08-2026: Board Meeting
14-08-2026 | 06:07 pm
14-08-2026 | 06:07 pm
Novyra Pharmachem's Board has approved financial results for the quarter. The company posted revenue of 172.61 and a net loss of (1.99), leading to an EPS of (0.03). Business operations were also reviewed.
No comments yet. Be the first to comment!
